文献速递腹部MR

胰腺囊性肿瘤MRI征象判读一致性:单中心回顾性研究

Interobserver agreement in MRI assessment of pancreatic cystic neoplasms: a retrospective single-center study.
PubMed 文献 · Abdom Radiol (NY) · 2026-07-25

本研究回顾性纳入23例患者共25个胰腺囊性肿瘤,由3名腹部影像专科医师依据2017修订版福冈指南独立评估MRI/MRCP征象。结果显示病灶部位、大小及形态一致性较好,而胰管沟通、囊壁强化、实性成分等定性征象一致性差。提示需标准化判读标准与结构化报告以提高风险分层一致性。

要点

  • 病灶部位、大小、形态是MRI评估PCN较可靠的核心指标。
  • 胰管沟通、囊壁强化、实性成分判读一致性差,报告时应谨慎。
  • 壁结节在本队列中均判为无,提示发生率低但需大样本验证。

核心结论

  • 病灶部位、大小及形态学等客观征象在MRI评估PCN中观察者间一致性较好,可作为临床决策的主要依据。
  • 胰管沟通、囊壁强化及实性成分等定性征象可重复性差,可能导致风险分层不一致。
  • 需要标准化判读标准、结构化报告模板及定量影像工具以提高PCN诊断一致性。

研究设计与样本

  • 回顾性单中心研究,纳入23例患者共25个胰腺囊性肿瘤病灶。
  • 3名经专科培训的腹部影像医师独立阅片,年资为专科培训后5至10年。
  • 使用MRI/MRCP检查作为影像评估手段,阅片者对临床资料和彼此评估结果均不知情。
  • 评估清单依据2017年修订版福冈指南预先设定。

关键影像表现/征象

  • 囊壁强化为定性征象,观察者间仅达轻度一致。
  • 实性成分判读一致性未超过偶然水平。
  • 胰管沟通征象判读仅为轻度一致。
  • 胰管直径测量为连续性变量,观察者间一致性中等。

诊断标准与关键数值

  • 病灶部位一致性kappa=0.75(p<0.0001),为高度一致。
  • 囊肿大小一致性kappa=0.62(p<0.0001),为高度一致。
  • 形态学类型一致性kappa=0.60(p<0.0001),为高度一致。
  • 胰管直径ICC=0.52(p<0.0001),为中等一致。
  • 囊壁厚度kappa=0.31(p=0.008),为中等一致。

临床应用与阅片要点

  • 日常报告中应优先以病灶部位、大小、形态作为PCN风险分层的主要依据。
  • 对于胰管沟通、囊壁强化、实性成分的判读应意识到观察者间变异较大,报告时需谨慎措辞。
  • 建议采用结构化报告模板以约束定性征象的判读流程。
  • 可借助定量影像工具辅助胰管直径及囊壁厚度等连续性指标的测量。

局限性

  • 本研究为单中心回顾性设计,结论外推需谨慎。
  • 样本量有限,仅纳入25个胰腺囊性肿瘤病灶。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Accurate MRI characterization of pancreatic cystic neoplasms (PCNs) is essential for risk stratification and clinical decision-making. Despite their widespread use, the reproducibility of several MRI features incorporated into international guidelines remains poorly studied, particularly in MRI-based evaluation. We evaluated interobserver agreement among fellowship-trained abdominal radiologists in assessing MRI features of PCNs according to the revised Fukuoka guidelines.

MATERIALS AND METHODS: In this retrospective single-center study, three fellowship-trained abdominal radiologists (5-10 years post-fellowship experience) independently reviewed MRI/MRCP examinations of 23 patients harboring 25 PCNs. Readers were blinded to clinical data and each other's assessments. A predefined checklist based on the 2017 revised Fukuoka guidelines was used to evaluate imaging features including cyst size, location, morphology, main pancreatic duct (MPD) diameter, ductal communication, mural nodules, solid components, wall characteristics, and wall enhancement. Interobserver agreement was quantified using Fleiss' kappa for categorical variables (with pairwise Cohen's kappa), and the intraclass correlation coefficient (ICC) for continuous variables. Kappa values were interpreted using the Landis and Koch scale.

RESULTS: Substantial agreement was observed for lesion location (kappa = 0.75, p < 0.0001), cyst size (kappa = 0.62, p < 0.0001), and morphological form (kappa = 0.60, p < 0.0001). Moderate agreement was noted for MPD diameter (ICC = 0.52, p < 0.0001), wall thickness (kappa = 0.31, p = 0.008), and signs of chronic pancreatitis (kappa = 0.36, p = 0.002). Fair agreement was found for ductal communication (kappa = 0.18, p = 0.041) and wall enhancement (kappa = 0.20, p = 0.089), while solid components showed no agreement beyond chance (kappa = - 0.03, p = 0.812). Mural nodules showed 100% agreement attributable to their absence in this cohort.

CONCLUSION: Objective MRI features such as lesion size and morphology showed consistently good agreement between readers, supporting their use as primary criteria in clinical decision-making. However, qualitative features including ductal communication, wall enhancement, and solid components show poor reproducibility, potentially leading to inconsistent risk stratification. Our results highlight the need for standardized interpretation criteria, structured reporting templates, and quantitative imaging tools to improve diagnostic consistency in PCN evaluation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alamri, Al-Ghamdi, Hakobyan, et al. Interobserver agreement in MRI assessment of pancreatic cystic neoplasms: a retrospective single-center study. Abdom Radiol (NY). 2026. PMID: 42501098. doi:10.1007/s00261-026-05709-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。